| Code | CSB-RA738603MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to BDC-3042, targeting CLEC6A (C-type lectin domain family 6 member A), also known as Dectin-2. CLEC6A is a pattern recognition receptor primarily expressed on myeloid cells, including dendritic cells and macrophages, where it plays a critical role in innate immune responses. This receptor recognizes fungal cell wall components and certain endogenous ligands, triggering inflammatory signaling pathways through Syk kinase activation. CLEC6A is implicated in various pathological conditions, including fungal infections, inflammatory diseases, and has been associated with immune responses in cancer and autoimmune disorders.
The reference antibody BDC-3042 has been utilized in immunological research to investigate CLEC6A expression patterns and functional roles in immune cell populations. This biosimilar provides researchers with a reliable tool for studying CLEC6A-mediated immune recognition, antifungal immunity, and inflammatory signaling mechanisms. It supports investigations into innate immune regulation, host-pathogen interactions, and the development of therapeutic strategies targeting CLEC6A-dependent pathways in infectious and inflammatory diseases.
There are currently no reviews for this product.